References
- Schwetz B. New treatment for chronic myeloid leukemia. JAMA 2001;286(1):35.
- Walid S, Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FE Imatinib (Gleevec)-induced hepatotoxicity. J Clin Gastroentero 2005;39(1):75–77.
- Cohen ME, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res 2002;8(5):935–934.
- Deininger Michael WN, O'Brien Stephen G, Ford John M, Druker Brian J. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003;:21, By American Society of Clinical Oncology.
- James C, Trouette H, Marit G, Cony-Makhoul P, Mahon FX. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 2003;17(5):978–979.
- Kikuchi S, Muroi K, Takahashi S, Kawano-Yamamoto C, Takatoku M, Miyazato A, Nagai T, Mori M, Komatsu N, Ozawa K. Severe hepatitis and complete molecular response caused by imatinib mesylate: Possible association of its serum concentration with clinical outcomes. Leuk Lymphoma 2004; 45(11):2349–2351.
- Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa H, Kimura Y, Serizawa H, Ebihara Y. Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia 2002;16(10):2160–2161.
- Ikeda K, Shiga Y, Takahashi A, Kai T, Kimura H, Takeyama K, Noji H, Ogawa K, Nakamura A, Ohira H, Sato Y, Maruyama Y. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma 2006;47(1):155–157.
- Batt AM, Ferrari L. Manifestations of chemically induced liver damage. Clin Chem 1995;41(12 Pt 2):1882–1887.
- Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trepo C, Zoulim F. Imatinib mesylate-induced acute cytolytic hepatitis. Gastroenterol Clin Biol 2004;28(10 Pt 1): 918–919.
- Parise RA, Ramanathan RK, Hayes MJ, Egorin MJ. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 791 (1-2):39–44.